Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of TW200744578ApublicationCriticalpatent/TW200744578A/en
Application grantedgrantedCritical
Publication of TWI393563BpublicationCriticalpatent/TWI393563B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Thiazole And Isothizaole Compounds
(AREA)
Abstract
The present invention is a use of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) as herein defined for the manufacture of a medicament for the treatment of obesity, for promoting weight loss and / or suppressing appetite.
TW95147358A2005-12-192006-12-18Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
TWI393563B
(en)
(3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity